Navigation Links
Pharma Opinions Site Reviews the Breakthrough Drugs of Pharmaceutical Companies
Date:10/21/2008

Quick glance at the latest new drugs. Pharma Opinions unveils a new site were top notch biotech companies will see their new approved products reviewed and commented.

Costa de Caparica, Portugal (PRWEB) October 21, 2008 -- A new blog review on the most recent approved drugs mainly in the U.S. Pharma Opinions unveils a new site were top notch biotech companies will see their new, approved products reviewed and commented on.

Breakthrough drugs and pharmaceutical companies are reviewed each time an approval is issued by FDA. The site extracts all the 'juicy' information from the companies Press Releases and puts it 'plain and simple' for the general opinion to understand the 'facts and figures' of the reason for the drug to be approved, and why it is such a breakthrough.

There will be also interviews with CEOs and officers of the pharmaceutical companies.

Among the most recent reviewed companies are Generex, Biovail and Cephalon

The blog is owned by Bruno Miguel Espalha, a portuguese 27 year old Pharmacist.

You can find the site at pharmaopinions.blogspot.com.

###

Read the full story at http://www.prweb.com/releases/pharmaceuticalblog/newdrugs/prweb1420944.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
2. Amylin Pharmaceuticals Reports Third Quarter Financial Results
3. New Pharmaceutical Company to Target Alzheimers Disease
4. Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
5. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
6. China Pharma Holdings, Inc. Appoints The Ruth Group
7. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
8. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
9. Bio-Pharma Industry Improves Patient Outcomes Through Continuing Medical Education (CME)
10. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
11. Rib-X Pharmaceuticals to Present at the 2008 ICAAC/IDSA Joint Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):